Abstract
Mesenchymal stem cells from Wharton's jelly of human umbilical cords (WJ-MSC) are a valuable alternate source of stem cells. Their role in situ and whether they can interact and cross intact endothelial monolayers requires elucidation. The aim of this study was to investigate the dynamic interactions between WJ-MSC and human umbilical vein endothelial cells (HUVEC), including attachment, transit times, extravasation pathway, and the effects of WJ-MSC on junctional vascular endothelial (VE)-cadherin. HUVEC were grown to near confluence in endothelial media and to full confluence in mixed media before the addition of PKH26-labelled WJ-MSC. Time lapse fluorescence microscopy showed stem cells undergoing membrane blebbing followed by amoeboid movement on HUVEC monolayers before rounding up and changing shape toward the spindle-shaped morphology during/after transmigration to subendothelial positions. Cells demonstrated a time lag of 60 min before paracellular extravasation, confirmed by confocal microscopy. Forty-six percent of attached cells crossed in the first 2 h. By 16 h, a majority of cells had transmigrated with >96% of cells crossing by 22 h. There were concomitant changes in endothelial junctional VE-cadherin with statistically significant increases in discontinuous staining at 2 h, return to control values at 16 h, even as from 22 h onward HUVEC displayed increased percentage of junctions with continuous staining and upregulation of protein. Our data suggests that WJ-MSC crosses the endothelial barrier through the paracellular pathway and can influence junctional organization of HUVEC with discreet perturbation of VE-cadherin preceding transmigration followed by upregulation once the adluminal side is reached. The latter may reflect a perivascular support function of WJ-MSC in the umbilical cord.
Introduction
The Wharton's jelly (WJ) of the umbilical cord is derived from the mesoderm of the primitive streak, which invades the connecting stalk and primary chorionic villi early in gestation. Mesenchymal stem cells (MSC) of the mesoderm differentiate into and participate in neovasculogenesis of both the umbilical and placental circulation. The WJ at term continues to encase the fetal umbilical vein and arteries (two) and still contain multipotent MSCs [1]. The role of these cells throughout gestation is not known, although paracrine cross-talk may be important for vessel growth, maturation, and function. MSCs from the umbilical cord can be easily isolated after parturition. Their phenotype is similar to adult bone marrow stem cells, but being fetal they have the added advantage of advanced potency and less immunogenicity than adult stem cells [2]. This makes them an attractive source for future stem cell therapy, although their fundamental biology still remains underresearched.
Currently, a large number of clinical trials are underway evaluating adult bone marrow-derived MSCs (BM-MSCs) for the treatment of cardiovascular, inflammatory, and autoimmune diseases. Most involve systemic infusion of MSC into the vascular circulation [3] and thus cells have to extravasate to target areas. In vitro studies have shown that MSC transmigrate, similar to leukocytes, through predominantly paracellular and also transcellular pathways in activated endothelium [4]. The authors reported that the initiation of transmigration occurred by 30 min with 50% of stem cells completing transmigration after 120 min. Using an isolated murine heart perfusion system, Schmidt et al. [5] have shown that MSC transmigrate through the paracellular junctions, with one third of the cells migrating within 30 min, suggestive of a faster transit time in vivo. Whether WJ-MSC uses the paracellular route and the duration of attachment and transmigration events is not known and is the central aim of this study.
In most non-CNS vascular beds, paracellular permeability is regulated in a dynamic manner by adherens junctions (AJs), with vascular endothelial (VE)-cadherin being the key player [6]. Phosphorylation of VE-cadherin and loss of anchorage leads to translocation of this molecule from adherens junctional domains and accompanying increased paracellular permeability to hydrophilic solutes and extravasating blood cells [5]. In the endothelium with tighter barriers, such as the blood–brain barrier, tight junctions also regulate the paracellular passage of cells, molecules, and ions. Human umbilical vein endothelial cells (HUVEC) are a useful and favored in vitro model for endothelial barrier studies and are easily isolated from the umbilical cord. The close proximity between the WJ-MSC and the umbilical vein endothelial cells in situ and their developmental origins makes the use of HUVEC doubly pertinent for this study. Using real-time fluorescence microscopy and confocal scanning microscopy, the cellular mechanisms used in the attachment and transmigration of WJ-MSC across HUVEC monolayers, the time taken, and the associated dynamics of the junctional VE-cadherin was, therefore, investigated. Data obtained may also reveal the importance of paracrine cross talk between umbilical stem cells and blood vessels for the continued maintenance of endothelial integrity during gestation.
Materials and Methods
Isolation and culture of cells
Term umbilical cords (n=20) were obtained at elective Cesarean section from normal pregnancies with informed patient consent, full ethical approval (REC Ref 14/SC/1194, NHS Heath Research Authority), and NHS permission from Nottingham University Hospitals, NHS Trust, UK. WJ-MSC were non-enzymatically isolated using the method of De Bruyn et al. [7]. WJ-MSC migrating from umbilical cord segments on plastic Petri dishes were cultured in a stem cell growth medium [DMEM/Low Glucose (Hyclone) with 15% fetal bovine serum (FBS; Sigma) and antibiotic/antimycotic solution (Hyclone)]. They were characterized according to the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy [8] by flow cytometry FC 500 (Beckman Coulter) with 50,000 events captured. Results were analyzed using the WEASEL v3.0 for Windows (Walter and Eliza Hall Institute). The ability to differentiate into adipocytes, chondrocytes (according to Pittenger et al. [9]), and osteocytes (according to Santos et al. [10]) was verified. Endothelial cells (HUVEC) were isolated from freshly collected term umbilical cords using the method of Hamilton and Leach [11]. They were grown up to passage 3 on gelatin-coated flasks and were maintained in endothelial medium [Medium 199 (Gibco) with 20% FBS+heparin sodium salt (50 μg/mL), endothelial cell growth supplement (50 μg/mL)]. The endothelial specific cell–cell adhesion molecule, VE-cadherin (Pharmingen, BD Biosciences) and von Willebrand Factor (vWF; Dako) was used to check the junctional maturity and homogeneity of HUVEC.
Effect of mixed media on the cells
Before the coculture study, the ability of HUVEC to attach and grow to confluence in mixed endothelial and stem cell growth media (50% endothelial medium+50% stem cell medium) was ascertained by microscopical observations. Changes, if any, of the endothelial markers VE-cadherin and vWF in HUVEC was investigated by immunocytochemistry (see Immunohistochemistry section below). WJ-MSC at passage 3, 4, and 5 were labeled with PKH26 fluorescent dye (Sigma-Aldrich) according to the manufacturer's instructions. Similarly, the ability of labeled WJ-MSC to attach, grow, and proliferate on 1% gelatin in mixed media was also investigated. WJ-MSC were cultured at an initial cell density of 64 cells/mm2 for 22 h. The attached cells were photographed and 10 unbiased images were taken for the 2, 16, and 22 h groups (three experimental repeats) using phase contrast microscopy. Every second image was selected from each group and the number of cells counted. The mean number of cells/mm2 was calculated. The labeled WJ-MSC were also subjected to immunocytochemistry to localize any VE-cadherin expression in mixed media.
Coculture studies
To obtain cocultures of HUVEC in contact with WJ-MSC, 100,000 HUVEC were seeded on a 1% gelatin-coated coverslip (19 mm diameter) and incubated in endothelial media (three different isolates were tested, with three experimental repeats). Once 70% confluence was reached, the media was changed to mixed media. On full confluence (18–24 h later) 20,000 labeled WJ-MSC were seeded on top of the confluent HUVEC monolayer (1:5 ratio) per coverslip in 1 mL of the mixed media [12]. HUVEC monolayers without added WJ-MSC in mixed media were used as a control. WJ–MSC–HUVEC interaction was observed at different time intervals (2, 4, 6, 22, and 26 h) by an inverted phase microscope and photographed.
Real time observations
Cocultures of WJ-MSC on HUVEC on glass-bottomed tissue culture dishes (Ibidi GmBH) were observed with DMIRE2 time-lapse fluorescent microscope with a built-in environmental chamber and a color CCD camera (Leica DC300FX) and also with a wide-field fluorescence microscope (Deltavision Elite; Applied Precision). Cells were observed for 40 h. All data analyses were carried out using the Volocity software (Perkin Elmer).
Immunohistochemistry of VE-cadherin and systematic random sampling
To localize VE-cadherin in HUVEC and monitor the effects of labeled WJ-MSC on VE-cadherin, cocultured cells were fixed with 1% paraformaldehyde, pH 7.3 at different time intervals (2, 4, 6, 12, 14, 16, 22, and 26 h). They were permeabilized for 10 min with 0.15% Triton X-100, blocked in 5% goat's serum in phosphate buffered saline (PBS) for 30 min and incubated overnight at 4°C with mouse anti-Human CD144 (VE-cadherin; 5 μg/mL). Cells were washed with 0.1% PBS/BSA and incubated with FITC-conjugated goat anti-mouse IgG (Sigma) for 2 h in the dark at room temperature (RT). The coverslips were mounted using Vectorshield. They were analyzed using a Nikon fluorescence microscope with appropriate filters to allow visualization of both FITC and PKH26. Localization and continuous/discontinuous staining pattern of endothelial cell–cell junctions and position of labeled WJ-MSC was photographed with the CCD camera (Nikon DS) for the chosen intervals of coculture and stored (NIS elements F3.0; Nikon). HUVEC alone and labeled WJ-MSC alone for similar durations of culture in mixed media were also subjected to VE-cadherin immunocytochemistry to obtain appropriate controls.
Junctional counts
Stored Images (duration of coculture was blinded) were used to count the percentage of paracellular clefts showing continuous or discontinuous (disrupted) VE-cadherin staining in control and treated HUVEC monolayers. To ensure that all cell–cell junctional regions had an equal chance of being counted, a grid was placed on images and paracellular clefts from every other square were counted and categorized according to staining pattern. The position and number of the labeled WJ-MSC, apical, or sub-endothelial and their proximity to discontinuous junctions were recorded for the cocultures.
Statistical analysis
Data were analyzed using the two-way ANOVA (Prism 6 software) and Bonferroni's multiple comparison test to compare control versus stem cell treated group at 2, 16, and 22 h. Tukey's multiple comparison test was used to compare controls alone and cocultures alone at the same time intervals. Statistical significance was taken at P<0.05.
Confocal imaging
Immunocytochemically labeled cocultures at 2 and 22 h were further analyzed with confocal scanning microscopy (Zeiss Axiovision; Zeiss) and the Zen 2009 software for multichannel acquisition and image processing. The pinhole diameter used in all confocal imaging was 1 airy unit. Optical slices (0.5–0.6 μm intervals) were taken and Z-tilts were obtained to visualize transmigration pathways.
Western blotting
Confluent HUVEC monolayers were cocultured with or without WJ-MSC (1:5 ratio). The early hours of interaction (0, 2 h) and late (22 h) were chosen to measure VE-cadherin protein levels. WJ-MSC alone was grown in mixed media on gelatin and cells at 0, 2, and 22 h were used for immunoblotting. Briefly, cells were scraped and lysed in a 200 μL Lysis buffer [20 mM Tris (Invitrogen)+320 mM sucrose (BDH)+0.1% Triton X-100+1 mM NaF+10 mM β glycerophoshate+1 mM EGTA and protease inhibitor; pH 7.6]. Denatured proteins were separated in a 4%–20% gradient polyacrylamide gel after equal loading (15 μL) and transferred to a nitrocellulose membrane. After blocking with 5% skimmed milk powder in 0.1% Tris buffered saline with Tween 20 for 60 min at RT, the membranes were incubated with the antibodies against VE-cadherin (1:1,000 dilution; Cell Signalling) and GAPDH (1:3,000; Sigma). A Li-cor Odyssey scanner and Odyssey software (Image Studio Version 3.1.4) were used to measure optical densities. The VE-cadherin protein expression (normalized using GAPDH as loading control) for the different durations and study groups (three experimental repeats) were obtained. Data were analyzed using two-way ANOVA and Sidak's multiple comparison test. Statistical significance was taken at P<0.05.
Results
Characterization of isolated WJ-MSC and HUVEC
Under our laboratory conditions, WJ-MSC took 25±5 days to migrate from cord segments, adhere, and reach confluence. In subsequent passages (up to P4) the confluence time was halved in each passage and the confluent cell counts reached to 5×106 cells/mL. Flow cytometric analysis of WJ-MSC from passage 3, 4, and 5 (before and after freezing) revealed (>95%) from each passage, and were positive for the mesenchymal markers CD29, CD105, CD90, CD73, whereas 74.9% were positive for CD44. Less than 2% of the cells showed positivity to the hematopoietic markers CD34, CDHLA-DR, CD14, CD19, and CD45 (Fig. 1). In addition, the cells were able to differentiate into trilineage mesenchymal cells such as adipocytes, chondrocytes, and osteocytes when induced (data not shown).
Confluent HUVEC (P2, P3) monolayers expressed VE-cadherin at cell–cell contacts. The pattern of staining was predominantly continuous (>90% of cell–cell borders; Fig. 2A).
Effect of mixed media on WJ-MSC and HUVEC
PKH26-labeled WJ-MSC displayed no alteration in morphology and retained the dye over an observed 10 days. They attached to 1% gelatin-coated coverslips and grew to 70% confluence by 22 h in mixed stem cell/endothelial media. The cells displayed proliferation: at 2 h, counts revealed a mean cell density of 82 cells/mm2, which increased to 320 cells/mm2 at 16 h, whereas at 22 h there were on average 487 cells per mm2 (Fig. 2D–F). The cells displayed the transition of cell shape—from rounded to intermediate to elongated spindle shaped with time over the observation period (Fig. 2D–I). They displayed negative immunoreactivity to anti-VE-cadherin antibodies (Fig. 2G–I). HUVEC also continued to show the typical cobblestone appearance and positivity to the endothelial marker before and after addition of the mixed media for the durations tested (Fig. 2A–C). Continuous VE-cadherin staining was seen in 88+1.6 SD% of cell–cell junctions when cells reached full confluence in mixed media.
Coculture studies
Early coculture interactions
With phase contrast microscopy, WJ-MSC were seen to attach to the HUVEC monolayer within 30 min and appeared to display morphological changes—from rounded to transitional to spindle shaped. The position of these cells in relation to the endothelial layer was difficult to decipher at the magnifications allowed. Real-time imaging (every 15 min) with a time lapse fluorescence microscope showed that soon after addition of PKH26-labeled WJ-MSC on HUVEC monolayers they displayed membrane blebbing (Fig. 3A, B) and shedding of PKH26-filled exosomes (Fig. 3C). The blebbing behavior was followed by pseudopodial extensions and amoeboid movement (Fig. 4) over HUVEC. Cells were then observed to round up and change shape toward the spindle-shaped morphology (Fig. 4). PKH26-filled exosomes were shed throughout this period.
Transmigration events
Fluorescent micrographs of immunostained cocultures from different durations showed that transmigration of cells from the apical surface to sub-endothelial layers started from 60 min onwards. At 2 h, 46%±11% of all attached WJ-MSC were found in sub-endothelial locations. At 16 h, the majority of WJ-MSC (95%±4%) was found in sub-endothelial position. 96%±3% of WJ-MSC were found in sub-endothelial positions at 22 h.
VE-cadherin dynamics
The pattern of VE-cadherin localization was observed to differ in HUVEC monolayers with or without added PKH26-labeled WJ-MSC at 2, 16, and 22 h. Control HUVEC monolayers (no added stem cells) showed the presence of VE-cadherin at cell–cell boundaries, with a predominant continuous staining pattern at all time points (Fig. 5). In cocultures, attachment and paracellular transmigration across the endothelial layer was observed from 2 h and was concomitant with changes in VE-cadherin staining pattern to a discontinuous, stitch-like, or no staining pattern in ∼35% of all cell–cell junctions. Specifically, HUVEC with overlying or transmigrating labeled WJ-MSC showed junctional disruption (Fig. 5B, C) compared with continuous VE-cadherin staining seen in HUVEC distant from WJ-MSC. A similar pattern of disruption related to stem cell proximity was seen in 16 h cocultures. The stem cells overlying HUVEC, traversing intercellular gaps and in sub-endothelial positions were all immunonegative to VE-cadherin. At 22 h all WJ-MSC were observed in sub-endothelial position with overlying paracellular clefts showing full occupancy of VE-cadherin (Fig. 5J–L).
Quantitative analyses (Fig. 5M) revealed a statistically significant decrease (64.9%; P<0.0001) in the percentage of cell–cell borders showing continuous VE-cadherin staining at 2 h compared to control HUVEC (80.9%±2.9%). At 16 h both control and treated groups had similar (76.9%±4.6% vs. 79.2%±3%) continuous junctional profiles. At 22 h, the percentage of continuous junctions were statistically higher (93.4±3.2) in the WJ-MSC-treated samples versus the control (78.8%±3.4%; P<0.001). Intraspecific comparisons of groups showed that junctional staining pattern in control HUVEC monolayers were not significantly different at 2, 16, and 22 h whereas in treated groups the percentage of continuous junctions differed at each time point of coculture (P<0.001).
Western blot analyses (n=3) of cocultures and control monolayers at 2 and 22 h showed that that WJ-MSC did not express VE-cadherin, whereas HUVEC showed differential expression dependent on treatment and duration of stem cell interaction (Fig. 5N). Statistical analysis revealed no significant change in VE-cadherin values (normalized against GAPDH) in the control groups from 2 to 22 h, whereas the cocultures showed significant upregulation of VE-cadherin protein in the same time interval (P≤0.01; Fig. 5O). This intraspecific difference corresponded with junctional changes seen by immunofluorescence analyses.
Confocal microscopy of cocultures, immunostained with VE-cadherin and tilting at the Z axis confirmed attachment and paracellular transmigration of WJ-MSC across the endothelial layer at 2 h, (Fig. 6A–D). Furthermore, Z-tilts confirmed basal position of all stem cells at 22 h (Fig. 6E–G). The endothelial cell–cell junctions showed the continuous VE-cadherin pattern above the transmigrated stem cells.
Discussion
This study showed that human MSCs isolated from the umbilical cord can cross the endothelial barrier without causing endothelial damage. The transmigration appeared to be similar to that shown for bone marrow stem cell migration [4], taking a period of hours rather than minutes. WJ-MSC demonstrated nonapoptotic blebbing upon addition, amoeboid motility, changes in cell shape, and paracellular transmigration to the sub-endothelial layer. Our data also suggests that WJ-MSC can influence junctional expression of the paracellular adhesion molecule VE-cadherin, with VE-cadherin perturbation as an early event followed by transmigration and a full return of VE-cadherin to junctional domains. Indeed, once WJ-MSC were in the sub-endothelial niche, they appeared to upregulate both VE-cadherin protein expression and their occupancy at HUVEC–cell borders.
Exposure of PH26-labeled WJ-MSC to 50% endothelial media did not alter their ability to attach, proliferate, grow to confluence, and retain the dye (Fig. 2). They did not demonstrate phenotypic alteration toward the endothelial lineage—they continued to be negative for VE-cadherin when grown in mixed media or when cocultured with HUVEC. Addition of 50% stem cell media to HUVEC at near confluence did not alter its ability to reach full confluence within 24 h. Junctional maturity (as evidenced by continuous VE-cadherin staining) and vWF expression was similar to that seen in HUVEC grown in 100% endothelial medium. There were no statistically significant differences in the percentage of junctions showing continuous VE-cadherin at 2, 16, or 22 h in mixed media alone (control; Fig. 5). In cocultures there was a significant upregulation of total protein in HUVEC after 96% of WJ-MSC had transmigrated to the adluminal (sub-endothelial) position. This increase was due to the changes in HUVEC since WJ-MSC remains immunonegative for VE-cadherin at all durations of coculture (Fig. 5N). However, where VE-cadherin resides, junctional occupancy rather than cytoplasmic location, dictates barrier integrity [6]. Thus the observed changes in junctional VE-cadherin staining with duration of coculture were revealing (Fig. 5). The statistically significant increase in disruption of the VE-cadherin AJs in the HUVEC monolayer was an early event and peaked at 2 h after introduction of WJ-MSC (Fig. 5). Transendothelial migration of WJ-MSC started from 60 min and ∼46% of cells had transmigrated by 2 h. Return of VE-cadherin and full junctional occupancy was a postmigratory event, starting around 16 h and reaching a higher percentage continuous than control HUVEC monolayers at 22 h. VE-cadherin protein expression was at its highest at this point.
The discreet but significant perturbations of HUVEC–cell borders, which started from 60 min are reminiscent of that seen for vasoactive agents such as VEGF and histamine [13,14]. These inflammatory mediators have a biphasic response with rapid transendothelial pore formation (minutes) followed by a paracellular distension after 30–60 min [15–17]. The delayed interaction we observed argues toward VE-cadherin relocation to facilitate transmigration. BM-MSC have been shown to migrate through the paracellular pathway of human brain micro-VE cell monolayers, through the disruption of ZO-1 and occludin and alteration of tight junction integrity [18]. The postmigratory return of VE-cadherin in our cocultures agrees with other studies. Pati et al. showed that BM-MSC can reduce HUVEC monolayers permeability in vitro after 24 h with enhanced VE-cadherin/β-catenin interactions [12]. Menge et al. showed that BM-MSC inhibit HUVEC proliferation and angiogenesis after 2 days of coculture through the modulation of VE-cadherin/β-catenin signaling pathway [19]. Our studies show that umbilical mesenchymal cells have a similar ability; moreover we show that this is preceded by paracellular VE-cadherin disruption during transmigration. The return of VE-cadherin and HUVEC confluence seems to be related to a paracrine conversation between WJ-MSC and HUVEC. According to [20] WJ-MSC can stimulate neovascularization by secreting paracrine factors and by acting as perivascular precursor cells. The observed shedding of exosomes before transmigration suggests that exosomal signaling may also be an early event (Figs. 3 and 4). Released exosomes from placental mesenchymal cells have been shown to have a dose-dependent effect on migration and tube formation of placental micro-VE cells [21]. Whether exosomal signaling can induce junctional disruption requires investigation and is underway in our laboratory.
Our real-time studies (Figs. 3 and 4) revealed that transmigration is not an all or nothing event, with all added cells transmigrating soon after addition. Increasing number of WJ-MSC crossed the endothelial barriers over the 24 h observation period, with migration starting around 60 min. Forty-six percent of attached cells crossed in the first 2 h and the remainder continued crossing up to the 24 h. The initial lag phase and prolonged duration is similar to an in vivo study of the perfused mouse heart, where Schmidt et al. reported that 50% of introduced bone marrow stem cells migrated through the endothelial barrier within 60 min perfusion [5]. We did not see any reverse trafficking of migrated cells. Once the sub-endothelial position was reached, cells attached and became quiescent. This may be the consequence of improved adhesion of WJ-MSC on gelatin. In our study we used isolated MSCs from the incised umbilical cord. These cells showed essential MSC characteristics such as plastic adherence, tripotency, and expression of CD29, CD105, CD90, CD73, and CD44. However, heterogeneous populations of MSCs, both in origin (pericytic or fibroblastic) and differentiation potency is now a hotly discussed topic [22] and may explain the reported vascular repair potential of MSCs. Of the 20,000 WJ-MSC added to each endothelial-lined well and grown in mixed media, only a proportion (∼50%) of the added stem cells crossed the endothelial barrier. The ability of this cohort to survive (adapt) in 50% endothelial media and their preference for the sub-endothelial niche is suggestive of the existence of cells with different lineage potential in the >96% pure characterized MSCs. Thus these stem cells may be more amenable to perivascular lineage commitment. Indeed the subsequent maturation of endothelial VE-cadherin junctions seen in HUVEC at 22 h coculture mimics an endothelial-pericyte cross-talk and gives credence to this hypothesis.
The blebbing behavior of the WJ-MSC upon introduction was observed not to be an apoptotic phenomenon. The very same cells were then seen to display amoeboid movement and change shape (Fig. 4). This type of membrane changes after trypsinization of adhered cells and addition to new extracellular matrix has been shown for cells; indeed bled-mediated migration for navigation and mechanical homeostasis is a critical cellular activity [23]. Teo et al. [4] also attributed blebbing of bone marrow stem cells to low avidity interaction between endothelium and MSC, whereas quenching of blebbing may be promoted by contact with the sub-endothelial matrix after transmigration. WJ-MSC in our study showed exactly the same response in their search for new optimal attachment sites at the sub-endothelial niches (Figs. 3 and 4). As stated before, in our study, confocal microscopy and Z-tilting indicate that emigration sites for WJ-MSC were at cell–cell contact regions (Fig. 6). Transcellular migration was not observed, but cannot be excluded. The time taken to transmigrate was similar to that seen for bone marrow stem cells rather than leucocytes [24].
In conclusion, this study is the first to show the early events of transmigration of WJ-MSC isolated from the human umbilical cord through HUVEC. Our data adds strength to the observations that alteration in VE-cadherin localization at junctional domains accompanies MSC migration to perivascular regions. The traffic to sub-endothelial regions and influence on endothelial integrity and VE-cadherin occupancy suggest that WJ-MSC have an important perivascular/pericytic function, in general, and throughout gestation, in particular.
Acknowledgments
The authors wish to thank the staff and patients of Labor Suite, Queens Medical Centre, Nottingham for their help and generosity. The authors thank Dr. Emma King, Advanced Imaging Unit, for her advice on real-time imaging. The DeltaVision Microscope used was funded by the Wellcome Trust, 094233/Z/10/Z. Thanks also to the Islamic Development Bank (IDB) for funding the PhD studentship of N.E.
Data from this article was presented as a poster in British Microcirculation Society's annual meeting in University of Bristol, April 2014.
Author Disclosure Statement
No competing financial interests exist.
References
- 1.Kobayashi K, Kubota T. and Aso T. (1998). Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev 51:223–233 [DOI] [PubMed] [Google Scholar]
- 2.Fan CG, Zhang QJ. and Zhou JR. (2011). Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7:195–207 [DOI] [PubMed] [Google Scholar]
- 3.Sokolova IB, Zin'kova NN, Shvedova EV, Kruglyakov PV. and Polyntsev DG. (2007). Distribution of mesenchymal stem cells in the area of tissue inflammation after transplantation of the cell material via different routes. Bull Exp Biol Med 143:143–146 [DOI] [PubMed] [Google Scholar]
- 4.Teo GS, Ankrum JA, Martinelli R, Boetto SE, Simms K, Sciuto TE, Dvorak AM, Karp JM. and Carman CV. (2012). Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-alpha-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 30:2472–2486 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schmidt A, Ladage D, Steingen C, Brixius K, Schinkothe T, Klinz FJ, Schwinger RH, Mehlhorn U. and Bloch W. (2006). Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol 85:1179–1188 [DOI] [PubMed] [Google Scholar]
- 6.Dejana E, Orsenigo F. and Lampugnani MG. (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115–2122 [DOI] [PubMed] [Google Scholar]
- 7.De Bruyn C, Najar M, Raicevic G, Meuleman N, Pieters K, Stamatopoulos B, Delforge A, Bron D. and Lagneaux L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev 20:547–557 [DOI] [PubMed] [Google Scholar]
- 8.Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj. and Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317 [DOI] [PubMed] [Google Scholar]
- 9.Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S. and Marshak DR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147 [DOI] [PubMed] [Google Scholar]
- 10.Santos JM, Barcia RN, Simoes SI, Gaspar MM, Calado S, Agua-Doce A, Almeida SC, Almeida J, Filipe M, et al. (2013). The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX(R)) in the treatment of inflammatory arthritis. J Transl Med 11:18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hamilton RD. and Leach L. (2011). Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol Biol 686:401–416 [DOI] [PubMed] [Google Scholar]
- 12.Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, et al. (2011). Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev 20:89–101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Esser S, Lampugnani MG, Corada M, Dejana E. and Risau W. (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111:1853–1865 [DOI] [PubMed] [Google Scholar]
- 14.Leach L, Eaton BM, Westcott ED. and Firth JA. (1995). Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res 50:323–337 [DOI] [PubMed] [Google Scholar]
- 15.Absi M, Bruce JI. and Ward DT. (2014). The inhibitory effect of simvastatin and aspirin on histamine responsiveness in human vascular endothelial cells. Am J Physiol Cell Physiol 306:C679–C686 [DOI] [PubMed] [Google Scholar]
- 16.Bates DO. (2010). Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87:262–271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wegener J. and Seebach J. (2014). Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches. Cell Tissue Res 355:485–514 [DOI] [PubMed] [Google Scholar]
- 18.Lin MN, Shang DS, Sun W, Li B, Xu X, Fang WG, Zhao WD, Cao L. and Chen YH. (2013). Involvement of PI3K and ROCK signaling pathways in migration of bone marrow-derived mesenchymal stem cells through human brain microvascular endothelial cell monolayers. Brain Res 1513:1–8 [DOI] [PubMed] [Google Scholar]
- 19.Menge T, Gerber M, Wataha K, Reid W, Guha S, Cox CS, Jr., Dash P, Reitz MS, Jr., Khakoo AY. and Pati S. (2013). Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/beta-catenin signaling pathway. Stem Cells Dev 22:148–157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Choi M, Lee HS, Naidansaren P, Kim HK.O E, Cha JH, Ahn HY, Yang PI, Shin JC. and Joe YA. (2013). Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45:560–570 [DOI] [PubMed] [Google Scholar]
- 21.Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M. and Rice GE. (2013). Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 8:e68451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lv FJ, Tuan RS, Cheung KM. and Leung VY. (2014). The surface markers and identity of human mesenchymal stem cells. Stem Cells 32:1408–1419 [DOI] [PubMed] [Google Scholar]
- 23.Norman LL, Brugues J, Sengupta K, Sens P. and Aranda-Espinoza H. (2010). Cell blebbing and membrane area homeostasis in spreading and retracting cells. Biophys J 99:1726–1733 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Stock C. and Riethmuller C. (2011). Endothelial activation drives lateral migration and diapedesis of leukocytes. Cell Immunol 271:180–183 [DOI] [PubMed] [Google Scholar]